SCHEMBL8285286

SCHEMBL8285286

O=c1cc(Nc2ccccc2)n(-c2ccccc2)c2cc(COc3ccncc3)ncc12

nearest known ligand 0.36

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 3/20 0.36
MAPT P10636 1/20 0.34
HRH2 P25021 1/20 0.33
HRH1 P35367 1/20 0.33
HRH3 Q9Y5N1 1/20 0.33
PDE10A Q9Y233 2/20 0.33
GSK3B P49841 3/20 0.33
F2 P00734 2/20 0.33
KCNH2 Q12809 1/20 0.33
GRIN2B Q13224 1/20 0.33
CDK4 P11802 3/20 0.32
CCND1 P24385 1/20 0.32
CCND2 P30279 1/20 0.32
CCND3 P30281 1/20 0.32
PDE11A Q9HCR9 1/20 0.32
CDK6 Q00534 2/20 0.31
F10 P00742 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8286453 0.94 GSK3B (0.35) GRM5GSK3BKCNH2CDK4CCND1
SCHEMBL8287502 0.90 GRM5 (0.39) GRM5MAPTGSK3BCDK4CCND1
SCHEMBL8286505 0.89 CYP1A2 (0.41) GRM5MAPT
SCHEMBL8285279 0.86 MAT2A (0.34) GRM5GSK3BGRIN2BCDK4CCND1
SCHEMBL8287498 0.85 GSK3B (0.37) PDE10AGSK3BCDK4CCND1CCND2
SCHEMBL8285247 0.82 PDE11A (0.37) GRM5MAPTHRH2HRH1HRH3
SCHEMBL8286150 0.82 GSK3B (0.39) GSK3BCDK4CCND1CCND2CCND3
SCHEMBL8286162 0.82 GSK3B (0.37) MAPTGSK3BCDK4CCND1CCND2
SCHEMBL8287617 0.82 GSK3B (0.37) MAPTGSK3BCDK4CCND1CCND2
SCHEMBL8286148 0.81 GSK3B (0.36) GSK3BCDK4CCND1CCND2CCND3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed